Article
Advanced therapeutic approaches in sarcoglycanopathies.
Current opinion in pharmacology - 1 Jun 2024
Scano Martina, Benetollo Alberto, Dalla Barba Francesco, Sandonà Dorianna
Abstract excerpt
Sarcoglycanopathies are rare autosomal recessive diseases belonging to the family of limb-girdle muscular dystrophies. They are caused by mutations in the genes coding for α-, β-, γ-, and δ-sarcoglycan. The mutations impair the assembly of a key structural complex, which normally protects the sarcolemma of striated muscle from contraction-derived stress. Although heterogeneous, sarcoglycanopathies are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
